BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (AMEX: DDD) today reported financial results for the three and nine months ended September 30, 2006. Revenues for the three months ended September 30, 2006, increased significantly to $1,069,897 compared to $205,764 for the comparable period in 2005. For the nine months ended September 30, 2006, revenues increased to $1,441,922 compared to $449,055 for the same period in 2005.
